These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8000451)

  • 1. Endogenous drug-like factors in a Polish population.
    Mrozikiewicz A; Lowicki Z; Kowal J; Mrozikiewicz PM
    Pol J Pharmacol; 1994; 46(3):179-80. PubMed ID: 8000451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
    Oeltgen PR; Shank WA; Blouin RA; Clark T
    Ther Drug Monit; 1984; 6(3):360-7. PubMed ID: 6390799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
    Sedman AJ; Molitoris BA; Nakata LM; Gal J
    Am J Nephrol; 1986; 6(2):132-4. PubMed ID: 3085501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Abbott TDx for the stat measurement of phenobarbital, phenytoin, carbamazepine, and theophylline.
    Loomis KF; Frye RM
    Am J Clin Pathol; 1983 Nov; 80(5):686-91. PubMed ID: 6637881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a fluorescence polarization immunoassay system evaluated by therapeutic monitoring of four drugs.
    Zaninotto M; Secchiero S; Paleari CD; Burlina A
    Ther Drug Monit; 1992 Aug; 14(4):301-5. PubMed ID: 1519304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of two methods for therapeutic drug monitoring: FPIA (TDx) and Emit].
    Bogovskiĭ BP; Barmanova EIu
    Vopr Med Khim; 1991; 37(3):80-2. PubMed ID: 1949699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous quinidine-like immunoreactivity in the serum of rats with cardiac overload, stress or hyperthyroidism. Rapid communication.
    Schreiber V; Kölbel F; Hostlovská M; Nedvídková J
    Cor Vasa; 1993; 35(4):144-6. PubMed ID: 8403938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2006 Oct; 28(5):662-7. PubMed ID: 17038882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a new automated substrate-labeled fluorescence immunoassay system evaluated by comparative therapeutic monitoring of five drugs.
    Klotz U
    Ther Drug Monit; 1984; 6(3):355-9. PubMed ID: 6390798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interferences with plasma assays in therapeutic drug monitoring.
    Yosselson-Superstine S
    Clin Pharmacokinet; 1984; 9(1):67-87. PubMed ID: 6362953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microchip-based homogeneous immunoassay using fluorescence polarization spectroscopy.
    Tachi T; Kaji N; Tokeshi M; Baba Y
    Lab Chip; 2009 Apr; 9(7):966-71. PubMed ID: 19294309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics: the pharmacological monitoring of plasmatic levels in therapy.
    Bonora MR; Guaglio R; Terzoni PA; Rondanelli R
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):73-87. PubMed ID: 7372379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of phenytoin in sections of head hair: a preliminary study to evaluate the history of drug use.
    Tsatsakis AM; Psillakis T; Stefis A; Assithianakis P; Vlahonikolis IG; Michalodimitrakis MN; Helidonis E
    Boll Chim Farm; 1998 Dec; 137(11):459-66. PubMed ID: 10077879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.
    Amabeoku GJ; Chikuni O; Akino C; Mutetwa S
    East Afr Med J; 1993 Feb; 70(2):90-3. PubMed ID: 8513749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2007 Feb; 29(1):134-9. PubMed ID: 17333576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of carbamazepine and carbamazepine 10,11-epoxide in the fluorescence polarization immunoassay for tricyclic antidepressants: estimation of the true tricyclic antidepressant concentration in the presence of carbamazepine using a mathematical model.
    Dasgupta A; McNeese C; Wells A
    Am J Clin Pathol; 2004 Mar; 121(3):418-25. PubMed ID: 15023047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for determination of carbamazepine concentration in blood of poisoned patients.
    Wilimowska J; Gomółlka E; Pasich A; Jenner B; Szpak D
    Przegl Lek; 2005; 62(6):595-8. PubMed ID: 16225132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a free phenytoin assay on Cobas c501 analyzer using calibrators from Cobas Integra free phenytoin assay by comparing its performance with fluorescence polarization immunoassay for free phenytoin on the TDx analyzer.
    Dasgupta A; Davis B; Chow L
    J Clin Lab Anal; 2013 Jan; 27(1):1-4. PubMed ID: 23325740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.